DE69713865D1 - Basisch substituierte Vinylpyrrolidin-Cephalosporine - Google Patents

Basisch substituierte Vinylpyrrolidin-Cephalosporine

Info

Publication number
DE69713865D1
DE69713865D1 DE69713865T DE69713865T DE69713865D1 DE 69713865 D1 DE69713865 D1 DE 69713865D1 DE 69713865 T DE69713865 T DE 69713865T DE 69713865 T DE69713865 T DE 69713865T DE 69713865 D1 DE69713865 D1 DE 69713865D1
Authority
DE
Germany
Prior art keywords
hydrogen
formula
hydroxy
ylmethyl
omega
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69713865T
Other languages
English (en)
Other versions
DE69713865T2 (de
Inventor
Peter Angehrn
Paul Hebeisen
Ingrid Heinze-Krauss
Malcolm Page
Valerie Runtz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of DE69713865D1 publication Critical patent/DE69713865D1/de
Application granted granted Critical
Publication of DE69713865T2 publication Critical patent/DE69713865T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69713865T 1996-12-19 1997-12-11 Basisch substituierte Vinylpyrrolidin-Cephalosporine Expired - Lifetime DE69713865T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96120472 1996-12-19
EP97119528 1997-11-07

Publications (2)

Publication Number Publication Date
DE69713865D1 true DE69713865D1 (de) 2002-08-14
DE69713865T2 DE69713865T2 (de) 2003-02-20

Family

ID=26142379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69713865T Expired - Lifetime DE69713865T2 (de) 1996-12-19 1997-12-11 Basisch substituierte Vinylpyrrolidin-Cephalosporine

Country Status (20)

Country Link
US (1) US5981519A (de)
EP (1) EP0849269B9 (de)
JP (2) JP3264877B2 (de)
KR (3) KR100395985B1 (de)
CN (5) CN1104436C (de)
AT (1) ATE220402T1 (de)
AU (1) AU729653B2 (de)
CA (2) CA2224438C (de)
CY (1) CY2400B1 (de)
CZ (1) CZ405797A3 (de)
DE (1) DE69713865T2 (de)
DK (1) DK0849269T3 (de)
ES (1) ES2179996T3 (de)
HU (1) HUP9702474A3 (de)
IL (1) IL122604A0 (de)
MA (1) MA26457A1 (de)
NO (1) NO975901L (de)
NZ (1) NZ329363A (de)
PT (1) PT849269E (de)
TW (1) TW415949B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977381A (en) * 1998-01-12 1999-11-02 Hoffmann-La Roche Inc. Process for making 3-amino-pyrolidine derivatives
BRPI9911178B8 (pt) * 1998-06-15 2017-03-07 Basilea Pharmaceutica Ag derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos
US6232306B1 (en) * 1998-06-15 2001-05-15 Hoffmann-La Roche Inc. Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams
WO2000032605A1 (en) * 1998-12-03 2000-06-08 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
ATE370146T1 (de) 1999-07-05 2007-09-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von cephalosporin- derivaten
AU6267100A (en) * 1999-07-07 2001-01-30 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
DE60123513T2 (de) 2000-04-19 2007-05-10 Basilea Pharmaceutica Ag Verfahren zur Herstellung von D-Asparaginderivaten
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
JP3989832B2 (ja) * 2000-08-14 2007-10-10 バジリア ファルマスーチカ アーゲー N−保護−3−ピロリジン−ラクタム置換ホスホニウム塩類の調製方法
ITMI20012363A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Metodo per la sintesi di catene laterali di cefalosporine
ES2329244T3 (es) 2003-03-27 2009-11-24 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
US7511159B2 (en) * 2003-12-25 2009-03-31 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
US7569691B2 (en) * 2005-04-20 2009-08-04 Shin-Etsu Chemical Co., Ltd. Protected piperazino group-bearing organoxysilane compound and making method
CN101245079B (zh) * 2007-02-14 2010-07-07 山东轩竹医药科技有限公司 头孢抗生素衍生物
CN101245077B (zh) * 2007-02-14 2010-06-02 山东轩竹医药科技有限公司 头孢菌素衍生物
EA201070504A1 (ru) 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
CN101899059B (zh) * 2009-01-21 2012-02-15 山东轩竹医药科技有限公司 含有吡咯烷并环的头孢菌素衍生物
EP2435442B1 (de) * 2009-05-25 2016-01-13 Sandoz AG Verfahren zur herstellung von ceftobiprol medocaril
CN102030766B (zh) * 2009-09-30 2012-08-08 山东轩竹医药科技有限公司 含有二氢吡咯并杂环的头孢抗生素
CN103864851B (zh) * 2014-03-25 2016-08-17 华润赛科药业有限责任公司 作为前药的头孢吡普衍生物及其制备方法和用途
WO2024079094A1 (en) 2022-10-10 2024-04-18 Basilea Pharmaceutica International Ag, Allschwil Methods of treating staphylococcus aureus bacteremia infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
JPH08502513A (ja) * 1992-10-23 1996-03-19 藤沢薬品工業株式会社 セフェム化合物、およびそれらの医薬組成物
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
EP0620225B1 (de) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Cephalosporin-Derivate
DE69427365T2 (de) * 1993-09-29 2002-02-28 Meiji Seika Kaisha Neue cephalosporinderivate
JPH08319291A (ja) * 1995-05-25 1996-12-03 Meiji Seika Kaisha Ltd 新規セフェム誘導体
AT403161B (de) * 1995-07-19 1997-11-25 Biochemie Gmbh Verfahren zur herstellung von cephemverbindungen

Also Published As

Publication number Publication date
CN1347882A (zh) 2002-05-08
KR100331212B1 (ko) 2002-04-03
EP0849269B9 (de) 2003-03-05
EP0849269A1 (de) 1998-06-24
EP0849269B1 (de) 2002-07-10
CA2224438C (en) 2009-02-24
CA2224438A1 (en) 1998-06-19
JP4043203B2 (ja) 2008-02-06
PT849269E (pt) 2002-11-29
MA26457A1 (fr) 2004-12-20
CA2628224C (en) 2010-02-16
CA2628224A1 (en) 1998-06-19
ES2179996T3 (es) 2003-02-01
JP3264877B2 (ja) 2002-03-11
NO975901D0 (no) 1997-12-16
HU9702474D0 (en) 1998-03-02
TW415949B (en) 2000-12-21
HUP9702474A2 (hu) 1998-11-30
CY2400B1 (en) 2004-09-10
CN1132833C (zh) 2003-12-31
AU4846397A (en) 1998-06-25
CN1325850A (zh) 2001-12-12
DE69713865T2 (de) 2003-02-20
US5981519A (en) 1999-11-09
CN1347884A (zh) 2002-05-08
NZ329363A (en) 1999-01-28
KR100395985B1 (ko) 2004-02-14
JPH10182657A (ja) 1998-07-07
CN1188112A (zh) 1998-07-22
DK0849269T3 (da) 2002-10-28
CN1104436C (zh) 2003-04-02
CN1347883A (zh) 2002-05-08
CZ405797A3 (cs) 1998-07-15
JP2002060390A (ja) 2002-02-26
KR19980064240A (ko) 1998-10-07
AU729653B2 (en) 2001-02-08
NO975901L (no) 1998-06-22
ATE220402T1 (de) 2002-07-15
CN1163496C (zh) 2004-08-25
KR100310384B1 (ko) 2001-11-08
CN1183141C (zh) 2005-01-05
CN1198833C (zh) 2005-04-27
HUP9702474A3 (en) 2001-04-28
IL122604A0 (en) 1998-08-16

Similar Documents

Publication Publication Date Title
DE69713865D1 (de) Basisch substituierte Vinylpyrrolidin-Cephalosporine
DE68917023T2 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
ZA902378B (en) Cephalos porins and their homologues process for their preparation and pharmaceutical compositions
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
DE69429753D1 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
BRPI9705650A (pt) derivados de cefalosporinas, bem como processo para a fabricação , preparação farmacêutica e uso dos mesmos.
ES8702420A1 (es) Procedimiento para la obtencion de compuestos de aminoal- quilpenem
ECSP972346A (es) Cefalosporinas de vinil - pirrolidinonas con sustituyentes basicos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition